Zelquistinel
id:
zelquistinel-181-15767252
title:
Zelquistinel
text:
Zelquistinel is an orally active small-molecule NMDA receptor modulator which is under development for the treatment of major depressive disorder (MDD) by Gate Neurosciences, and previously by Allergan. Zelquistinel acts through a unique binding site on the NMDA receptor, independent of the glycine site, to modulate receptor activity and enhance NMDAR-mediated synaptic plasticity. Its mechanism of action is similar to that of rapastinel. However, unlike rapastinel, zelquistinel is orally bioavai
brand slug:
wiki
category slug:
encyclopedia
description:
Investigational antidepressant compound
original url:
https://en.wikipedia.org/wiki/Zelquistinel
date created:
2018-06-18T07:48:24Z
date modified:
2024-09-05T23:06:01Z
main entity:
{"identifier":"Q55602940","url":"https://www.wikidata.org/entity/Q55602940"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/c/c8/Zelquistinel.svg","width":512,"height":474}
fields total:
13
integrity:
16